ImatinibOncology News Saladax Biomedical Announces U.S. Launch of MyImatinib™ Chemotherapy Exposure Optimization Test Commercial Launch of MyImatinib™ Test Expands MyCare™ portfolio of Chemotherapy Exposure Optimization tests available from…John BuckleyDecember 1, 2014
Oncology News Personalized Chemotherapy Tests Cleared for Use in China Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…John BuckleyJuly 23, 2014
